Neoadjuvant atezolizumab in combination with dual HER2 blockade plus epirubicin in women with early HER2-positive breast cancer: the randomized phase 2 ABCSG-52/ATHENE trial
新辅助阿特珠单抗联合双重 HER2 阻断疗法和表柔比星治疗早期 HER2 阳性乳腺癌女性患者:随机 II 期 ABCSG-52/ATHENE 试验
期刊:Nature Cancer
影响因子:28.5
doi:10.1038/s43018-024-00890-2
Rinnerthaler, Gabriel; Egle, Daniel; Bartsch, Rupert; Schmitt, Clemens A; Petzer, Andreas; Balic, Marija; Petru, Edgar; Denison, Ursula; Singer, Christian F; Bjelic-Radisic, Vesna; Gampenrieder, Simon Peter; Knauer, Michael; Sotlar, Karl; Brunner, Christine; Posch, Florian; Hlauschek, Dominik; Sölkner, Lidija; Bago-Horvath, Zsuzsanna; Filipits, Martin; Gili, Manuela; Ritter, Magdalena; Wieser, Verena; Albertini, Carmen; Zaborsky, Nadja; Weiss, Lukas; Marhold, Maximilian; Schneeweiss, Bruno; Pusch, Renate; Gnant, Michael; Greil, Richard